Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Overall survival (OS) in gastrointestinal (GI) neuroendocrine tumors (NETs) based on primary site, stage, and surgery.
Authors
Bahar Laderian
Cleveland Clinic Lerner College of Medicine, Cleveland, OH;
Bahar Laderian , Nicole Farha , Prabhjot Singh Mundi , Wei Wei , Alok A. Khorana , Michelle Kang Kim , Scott Steele , Emre Gorgun , Antonio Tito Fojo , Smitha S. Krishnamurthi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 643)
DOI
10.1200/JCO.2023.41.4_suppl.643
Abstract #
643
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.
First Author: Geoff Hall
Poster
2020 Gastrointestinal Cancers Symposium
Trends of survival based on race and ethnicity in gastrointestinal tract neuroendocrine tumor.
First Author: Suleyman Yasin Goksu
Poster
2019 Gastrointestinal Cancers Symposium
Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
First Author: Nicholas Manguso
Poster
2019 Gastrointestinal Cancers Symposium
On the road again: Travel patterns and outcomes in rectal cancer.
First Author: Mary Kledzik